II. Indications
III. Mechanism
- Selective Aldosterone Receptor Antagonist
- More selective for Aldosterone than Spironolactone
- These agents are also Potassium-Sparing Diuretics
V. Contraindications
- Serum Potassium >5.0 mEq/L
- Type II Diabetes Mellitus with Microalbuminuria
-
Renal Insufficiency
- Serum Creatinine >2.5
- Anuria
VI. Dosing
-
Hypertension
- Start: 50 mg orally daily
- Decrease starting dose to 25 mg orally daily if using strong Cytochrome P450 3A4 inhibitor
- May increase to 50 mg orally twice daily after 4 weeks
- Start: 50 mg orally daily
-
Congestive Heart Failure
- Start: 25 mg orally daily for 4 weeks (then increase to target dose if tolerated)
- Target: 50 mg orally daily
VII. Adverse Effects
VIII. Drug Interactions
- Increased Serum Potassium (Hyperkalemia risk)
- Potassium Supplementation
- NSAIDs
- ACE Inhibitor
- Trimethoprim-Sulfamethoxazole
-
Digoxin
- Increased Digoxin Toxicity risk via increased Digoxin half life
-
Norepinephrine
- Decreases NorepinephrineVasopressor activity
-
Cytochrome P450 3A4 inhibitors (e.g. Ketoconazole)
- Significantly increases Eplerenone levels
IX. References
- Olson (2020) Clinical Pharmacology, Medmaster, Miami, p. 62-3
- Hamilton (2010) Tarason Pocket Pharmacopeia, p. 74
- (2003) Lexi-Comp Drug Database
- (2003) Med Lett Drugs Ther 45(1156):39-40 [PubMed]
- Stier (2003) Heart Dis 5(2):102-18 [PubMed]
Images: Related links to external sites (from Bing)
Related Studies
eplerenone (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
EPLERENONE 25 MG TABLET | Generic | $0.65 each |
EPLERENONE 50 MG TABLET | Generic | $0.77 each |